New Treatment for Prostate Cancer Performed at LHSC

The London Health Sciences Center has announced that a new, minimally invasive procedure to treat prostate cancer has been performed successfully.

 The new treatment, developed in collaboration with the Lawson Health Research Institute, allows for treatment to be performed in a single session using 'transurethral magnetic resonance guided ultrasound ablation', and allows for the procedure to be performed with greater accuracy.

 This treatment comes as a hopeful alternative to traditional treatments such as radiation therapy and surgery, which are often successful but leave many patients with long-term complications.

Dr. Joseph Chin, chief of surgical oncology at LHSC said in a statement to the CBC “This represents significant advance in the management of prostate cancer…Magnetic resonance image guidance allows us to target prostate tissue, using ultrasound energy without harming healthy tissue outside the prostate... We hope the clinical trial will show that this system can provide an effective and minimally invasive treatment for localized prostate cancer, with minimal side effects."